Application
LDHD Antibody (N-term) western blot analysis in HepG2 cell line lysates (15ug/lane).This demonstrates the LDHD antibody detected the LDHD protein (arrow).
Application
LDHD Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the LDHD Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
LDHD Antibody (N-term) flow cytometric analysis of HepG2 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.